News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Onco-Innovations partners with Nucro-Technics for preclinical studies on PNKP inhibitor, critical step towards human trials. Strategic collaboration with GLP and GMP experienced CRO -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Welcomes AstraZeneca's Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
Onco-Innovations' Inka Health receives Expression of Interest from AstraZeneca to join PROmAI Consortium, advancing AI solutions in oncology. AstraZeneca's involvement reinforces the Consortium's mission of enhancing predictive cancer research -
-